Recognition and Treatment of Thrombotic Thrombocytopenic Purpura
ACEP Now
APRIL 5, 2024
1 However, many clinical features are common: more than 60 percent of patients present with a degree of neurological involvement, ranging from confusion to stroke and coma. 1 Rituximab may be given as well, largely due to prevention of relapse. Even relatively small amounts of anti-ADAMTS13 autoantibodies can lead to TTP.
40 
Let's personalize your content